中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

经颈静脉肝内门体分流术后支架功能障碍的原因分析及处理策略

姚欣 周昊 汤善宏 谢敏 黄山 秦建平

引用本文:
Citation:

经颈静脉肝内门体分流术后支架功能障碍的原因分析及处理策略

DOI: 10.3969/j.issn.1001-5256.2019.05.023
基金项目: 

原成都军区总医院基金项目(2013YG-B009); 

详细信息
  • 中图分类号: R657.3

Stent dysfunction after transjugular intrahepatic portosystemic shunt: Causes and countermeasures

Research funding: 

 

  • 摘要: 目的探讨经颈静脉肝内门体分流术(TIPS)术后COOK裸支架、Wallgraft覆膜支架和Fluency覆膜支架3种血管支架出现功能障碍的原因及处理策略。方法收集2011年1月-2017年7月于西部战区总医院随访的支架功能障碍并行TIPS修正术患者54例的临床资料。术中通过造影及门静脉压力的情况,选择球囊扩张术、同轴支架置入术和平行TIPS术修正支架功能障碍。采用Kruskal-Wallis H检验比较3种支架狭窄或闭塞时间,采用配对t检验比较修正前后PVP。通过影像学资料判断支架功能障碍情况,分析支架狭窄或闭塞的原因。结果 54例患者全部成功实施TIPS修正,狭窄部位分别发生在肝静脉段、肝实质或门静脉段,高发时间窗为术后6~24个月。COOK支架、Wallgraft支架、Fluency支架狭窄或闭塞中位时间分别为17. 0、10. 0、17. 0个月。COOK支架和Fluency支架发生狭窄或闭塞时间晚于Wallgraft支架(P值分别为0. 013、0. 023),COOK支架和Fluency支架发生狭窄或闭塞时间差异无统计学意义(P=0. 893)。应用修正术式方面,球囊扩张4例...

     

  • [1] Interventional Group, Chinese Society of Radiology, Chinese Medical Association. Expert consensus on transjugular intrahepatic portosystemic shunt[J]. J Clin Hepatol, 2017, 33 (7) :1218-1228. (in Chinese) 中华医学会放射学分会介入学组.经颈静脉肝内门体分流术专家共识[J].临床肝胆病杂志, 2017, 33 (7) :1218-1228.
    [2] TRIPATHI D, FERGUSON J, BARKELL H, et al. Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents[J]. Eur J Gastroenterol Hepatol, 2006, 18 (3) :225-232.
    [3] JOSE B, RIPOLL C, BANARES R, et al. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents[J]. Eur J Radiol, 2005, 55 (1) :120-124.
    [4] TRIPATHI D, FERGUSON J, BARKELL H, et al. Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents[J]. Eur J Gastroenterol Hepatol, 2006, 18 (3) :225-232.
    [5] BARRIO J, RAFAEL C, BANARE R, et al. Comparison of transjugular intrahepatic portosystemic shunt dysfunt dysfunction in PTFE-covered stent-grafts versus bare stents[J]. Eur J Radiol, 2005, 5 (1) :120-124.
    [6] QIN JP, JIANG MD, TANG W, et al. Clinical effects and complications of TIPS for portal hypertension due to cirrhosis:A single center[J]. World J Gastroenterol, 2013, 19 (44) :8085-8092.
    [7] QIN JP, TANG W, TANG SH, et al. Modified transjugular intrahepatic portoststemic shunt in the treatment of portal hypertension of liver cirrhosis[J]. Chin J Dig, 2014, 4 (13) :33-36. (in Chinese) 秦建平, 唐文, 汤善宏, 等.改良经颈静脉肝内门体静脉分流术治疗肝硬化门静脉高压症[J].中华消化杂志, 2014, 34 (1) :33-36.
    [8] LABERGE JM, FERRELL LD, RING EJ, et al. Histopathologic study of transjugular intrahepatic portosystemic shunts[J]. J Vasc Interv Radiol, 1991, 2 (4) :549-556.
    [9] LABERGE JM, FERRELL LD, RING EJ, et al. Histopathologic study of stenotic and occluded transjugular intrahepatic portosystemic shunts[J]. J Vasc Interv Radiol, 1993, 4 (6) :779-786.
    [10] ROSSI P, SALVATORI FM, FANELLI F, et al. Polytetrafluoroethylene-covered nitinol stent-graft for transjugular intrahepatic portosystemic shunt creation:3-year experience[J].Radiology, 2004, 231 (3) :820-830.
    [11] VIGNALI C, BARGELLINI IM, PASSALACQUA G, et al. TIPS with Expanded polytetrafluoroethylene-covered stent:Results of an Italian multicenter study[J]. AJR Am J Roentgenol, 2005, 185 (2) :472.
    [12] ANGELONI S, MERLI M, SALVATORI FM, et al. Polytetrafluoroethylene-covered stent grafts for TIPS procedure:1-year patency and clinical results[J]. Am J Gastroenterol, 2004, 99 (2) :280-285.
    [13] SAXON RR, MENDEL HJ, CORLESS CL, et al. Bile duct injury as a major cause of stenosis and occlusion in transjugular intrahepatic portosystemic shunts:Comparative histopathologic analysis in humans and swine[J]. J Vasc Interv Radiol, 1996, 7 (4) :487-497.
    [14] DUCOIN H, EL-KHOURY J, ROUSSEAU H, et al. Histopathologic analysis of transjugular intrahepatic portosystemic shunts[J]. Hepatology, 1997, 25 (5) :1064-1069.
    [15] SANYAL AJ, CONTOS MJ, YAGER D, et al. Development of pseudointima and stenosis after transjugular intrahepatic portasystemic shunts:Characterization of cell phenotype and function.[J]. Hepatology, 2010, 28 (1) :22-32.
    [16] CLARK TW, AGARWAL R, HASKAL ZJ, et al. The effect of initial shunt outflow position on patency of transjugular intrahepatic portosystemic shunts[J]. J Vasc Interv Radiol, 2004, 15 (2) :147-152.
    [17] MATTSSON EJ, KOHLER TR, VERGEL SM, et al. Increased blood flow induces regression of intimal hyperplasia[J]. Arterioscler Thromb Vasc Biol, 1997, 17 (10) :2245-2249.
    [18] BUREAU C, GARCIA-PAGAN JC, OTAL P, et al. Improved clinicaloutcome using polytetrafluoroethylene-coated stents for TIPS:Results of a randomized study[J]. Gastroenterology, 2004, 126:469-475.
    [19] MASSON S, MARDINI HA, ROSE JD, et al. Hepatic encephalopathyafter transjugular intrahepatic portosystemic shunt insertion:Adecade of experience[J]. QJM, 2008, 101 (6) :493-501.
    [20] HASKAL ZJ, RADHAKRISHNAN J. Transjugular intrahepatic portosystemicshunts in hemodialysis-dependent patients and patients withadvanced renal insufficiency:Safety, caution, and encephalopathy[J]. J Vasc Interv Radiol, 2008, 19 (4) :516-520.
    [21] LUO XF, NIE L, WANG Z, et al. Stent-grafts for the treatment of TIPS dysfunction:Fluency stent vs Wallgraft stent[J].World J Gastroenterol, 2013, 19 (30) :5000-5005.
    [22] CLARK TW, AGARWAL R, HASKAL ZJ, et al. The effect of initial shunt outflow position on patency of transjugular intrahepatic portosystemic shunts[J]. J Vasc Interv Radiol, 2004, 15 (2) :147-152.
    [23] KRAJINA A, LOJIK M, CHOVANEC V, et al. Stent-grafts in TIPS[J]. Abdom Imaging, 2004, 29 (1) :53-59.
  • 加载中
计量
  • 文章访问数:  1679
  • HTML全文浏览量:  26
  • PDF下载量:  311
  • 被引次数: 0
出版历程
  • 收稿日期:  2018-11-26
  • 出版日期:  2019-05-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回